May 22, 2013 10:43AM Notable Analyst Rating Changes 05/22: (BMY) (CREE) (TEX) Upgraded; (IGTE) (CCL) (NCT) Downgraded
Aug 28, 2012 03:42PM Barclays on U.S. Biopharmaceuticals: Fate of Nucs Under Harsh Scrutiny - More Angst for IDIX; GILD Widens Lead
Aug 24, 2012 10:50AM Notable Analyst Rating Changes 08/24: (USG) (TCB) (BMY) Upgraded; (ADSK) (GGP) (BIG) Downgraded
Aug 17, 2012 02:54PM Barclays Lowers Outlook on Idenix Pharmaceuticals (IDIX); Clarity on FDA Clinical Hold (BMY, VRTX, GILD)
Aug 2, 2012 10:38AM Gilead Sciences (GILD) Surges As Bristol-Myers' (BMY) Hep C Drug Has Major Setback
Aug 2, 2012 10:22AM Barclays Downgrades Bristol-Myers Squibb Co. (BMY) to Equalweight
Jul 6, 2012 04:26PM Top 10 News Items 7/2-7/6: Private Sector Showed Slowest Pace of Job Growth in 10 Months; Central Banks React; Mergers Get Serious on Monday
Jul 2, 2012 03:10PM Barclays on AstraZeneca (AZN): Acquisition of AMLN Makes Strategic Sense but High Price Tag
May 25, 2012 01:40PM Barclays Remains Bullish on Vertex (VRTX); Upside to Phase I Data
May 11, 2012 01:26PM Barclays on Healthcare: Top Takeaways from our Second Annual Therapeutics Symposium
Dec 13, 2011 11:39AM Barclays 2012 Top Picks: Becoming Somewhat More Optimistic - Signs of Progress, Growth and Soft Landings
Oct 28, 2011 03:04PM Barclays Mintains an 'Overweight' on Bristol-Myers (BMY); Steady Pipeline Execution in Q3: November an Icremental Mnth for Eliquis
Oct 28, 2011 10:53AM Notable Analyst Rating Changes 10/28: (AMD) (LLY) (GS) Upgraded; (MDR) (BMY) (ED) Downgraded
Oct 13, 2011 02:32PM Barclays on U.S. Major Pharmaceuticals: Q3 Preview: BMY and PFE to Stand Apart From the Defensive Play Story
Sep 19, 2011 09:25AM Pre-Open Movers 9/19: (GR) (TYC) (LEN) Higher; (JKS) (AMAT) (RAH) Lower (more...)
Sep 14, 2011 12:45PM UPDATE - Barclays Downgraded Pfizer (PFE) to Equalweight; Inferior Revenue Recovery Post 'Patent Cliff' Through 2020
Jul 22, 2011 02:49PM Barclays Maintains an 'Equalweight' on Eli Lilly (LLY); No Signs of Fatigue at the Edge of the Cliff; Pipeline Risk Unabated
Jul 13, 2011 01:11PM Barclays on U.S. Diagnostics: FDA Issues draft guidance on companion diagnostics; Positive read for QGEN
Jun 23, 2011 03:27PM Barclays Maintains an 'Overweight' on Bristol-Myers (BMY); ARISTOTLE Delivers One-Two Punch; Eliquis Poised to be the Market Leader
Jun 16, 2011 02:23PM Barclays Maintains an 'Overweight' on Bristol-Myers Squibb (BMY); Nulojix Marks Second Hit in a Row; ARISTOTLE Top Line Remains The Focus
Jun 10, 2011 03:21PM Barclays on U.S. Major Pharmaceuticals: Pipelines Revived? Making Strides in Oncology, Cardiology, and Virology
May 16, 2011 02:05PM Global Pharmaceuticals: Global Therapeutic Conference 2011: Focus on Real-World Medicine
Apr 18, 2011 01:19PM Barclays Maintains an 'Overweight' on Bristol-Myers (BMY); Management Dinner Feedback: Myriad Options, but How to Go Foward in HCV?
Apr 14, 2011 01:25PM Barclays on U.S. Major Pharmaceuticals: 1Q11 Preview: Restructuring or New Products - Which Is The Lifeline For Pharma?
Apr 6, 2011 12:58PM Barclays Maintains an 'Overweight' on Bristol-Myers Squibb (BMY); Leading in the Evolving HCV Landscape
Mar 28, 2011 01:27PM Barclays Maintains an 'Overweight' on Bristol-Myers Squibb (BMY); Ipilimumab: Two Birds with One Stone
Jan 24, 2011 02:50PM Barclays on U.S. Major Pharmaceuticals: U.S. Major Pharma 2011 Outlook: A View Beyond the Cliff
Nov 19, 2010 01:55PM Barclays Maintains an 'Overweight' on Bristol-Myers Squibb (BMY); APPRAISE-2 Discontinuation Has Limited Implications for ARISTOTLE
Oct 14, 2010 04:22PM U.S. Major Pharmaceuticals: Q3 Preview: A hit but not a home run
Oct 4, 2010 09:24AM Daily State of the Markets 10/04: Pressing Pause (Again)
Jul 15, 2010 02:02PM Barclays Maintains an 'Overweight' on Bristol-Myers (BMY); Expect Outperformance With Core Franchise Stability
Mar 5, 2010 10:27AM Notable Analyst Rating Changes 03/05: DISH, TIVO, CWTR, CIEN, BMY Upgraded; WEN, TSN, AUY, WBD Downgraded
Jan 4, 2010 10:38AM Notable Analyst Rating Changes: MS, BA, UNH, INTC, UPL, FTO, More Upgraded; BMY, CHK, BSX, MELI, More Downgraded
Dec 22, 2009 10:41AM Notable Analyst Rating Changes 12/22: ATHX, IAG, BUCY, AMTD Upgraded; XTO, IMAX, WRC Downgraded
Nov 17, 2009 02:50PM Barclays Maintains an 'Overweight' on Bristol-Myers (BMY); Raises PT
Jul 15, 2009 10:14AM Notable Analyst Rating Changes 7/15: GS, ALU, ICE, MCO, ADBE, MI Upgraded; PTR, PAR, UFS, PCL Downgraded
Apr 29, 2009 10:09AM David Moenning's Daily State of the Markets: 4/29
Apr 29, 2009 09:57AM Notable Analyst Rating Changes 4/29: ATVI, OZM, AMX, DNDN Upgraded; BMY, WFMI, M, SFD Downgraded
Apr 3, 2009 09:49AM Notable Analyst Rating Changes 4/3: RIMM, DVN, ICE, ELN Upgraded; DIS, BMY, MON, AKAM Downgraded
Jan 27, 2009 10:41AM David Moenning's Daily State of the Markets: 1/27
Oct 23, 2008 10:07AM David Moenning's Daily State of the Markets: 10/23